Literature DB >> 9456440

Induction of IgG antibodies by an anti-idiotype antibody mimicking disialoganglioside GD2.

G Sen1, M Chakraborty, K A Foon, R A Reisfeld, M B Bhattacharya-Chatterjee.   

Abstract

The anti-idiotype (Id) monoclonal antibody (mAb) 1A7 immunoglobulin G1 (IgG1, kappa), raised in syngeneic mice against the murine anti-ganglioside GD2 mAb 14G2a mimics a carbohydrate epitope on GD2 and serves as a surrogate protein antigen for this disialoganglioside. Immunization of allogeneic C57BL/6 mice and rabbits with 1A7 induced anti-GD2 antibodies of IgG isotype that recognize purified GD2 by enzyme-linked immunosorbent assay (ELISA) and GD2-positive human melanoma cells (M21/P6) by fluorescence-activated cell sorter (FACS) analysis. The specificity of the antisera for GD2 was further confirmed by dot-blot analysis. These antisera also specifically lyse GD2-positive M21/P6 target cells in an antibody-dependent cellular cytotoxicity assay. Taken together, these results suggest that the anti-Id 1A7 can induce GD2-specific IgG antibodies that can recognize cell surface-associated as well as soluble disialoganglioside GD2.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9456440     DOI: 10.1097/00002371-199801000-00010

Source DB:  PubMed          Journal:  J Immunother        ISSN: 1524-9557            Impact factor:   4.456


  8 in total

1.  Enhanced safety and efficacy of protease-regulated CAR-T cell receptors.

Authors:  Louai Labanieh; Robbie G Majzner; Dorota Klysz; Elena Sotillo; Chris J Fisher; José G Vilches-Moure; Kaithlen Zen B Pacheco; Meena Malipatlolla; Peng Xu; Jessica H Hui; Tara Murty; Johanna Theruvath; Nishant Mehta; Sean A Yamada-Hunter; Evan W Weber; Sabine Heitzeneder; Kevin R Parker; Ansuman T Satpathy; Howard Y Chang; Michael Z Lin; Jennifer R Cochran; Crystal L Mackall
Journal:  Cell       Date:  2022-04-27       Impact factor: 66.850

2.  Neem leaf preparation enhances Th1 type immune response and anti-tumor immunity against breast tumor associated antigen.

Authors:  Ishita Mandal-Ghosh; Utpala Chattopadhyay; Rathindranath Baral
Journal:  Cancer Immun       Date:  2007-03-30

3.  Dual IGF1R/IR inhibitors in combination with GD2-CAR T-cells display a potent anti-tumor activity in diffuse midline glioma H3K27M-mutant.

Authors:  Emmanuel de Billy; Marsha Pellegrino; Domenico Orlando; Giulia Pericoli; Roberta Ferretti; Pietro Businaro; Maria Antonietta Ajmone-Cat; Sabrina Rossi; Lucia Lisa Petrilli; Nicola Maestro; Francesca Diomedi-Camassei; Marco Pezzullo; Cristiano De Stefanis; Paola Bencivenga; Alessia Palma; Rossella Rota; Francesca Del Bufalo; Luca Massimi; Gerrit Weber; Chris Jones; Andrea Carai; Simona Caruso; Biagio De Angelis; Ignazio Caruana; Concetta Quintarelli; Angela Mastronuzzi; Franco Locatelli; Maria Vinci
Journal:  Neuro Oncol       Date:  2022-07-01       Impact factor: 13.029

4.  4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors.

Authors:  Adrienne H Long; Waleed M Haso; Jack F Shern; Kelsey M Wanhainen; Meera Murgai; Maria Ingaramo; Jillian P Smith; Alec J Walker; M Eric Kohler; Vikas R Venkateshwara; Rosandra N Kaplan; George H Patterson; Terry J Fry; Rimas J Orentas; Crystal L Mackall
Journal:  Nat Med       Date:  2015-05-04       Impact factor: 53.440

Review 5.  Glycosylation of glycolipids in cancer: basis for development of novel therapeutic approaches.

Authors:  Jose L Daniotti; Aldo A Vilcaes; Vanina Torres Demichelis; Fernando M Ruggiero; Macarena Rodriguez-Walker
Journal:  Front Oncol       Date:  2013-12-19       Impact factor: 6.244

6.  Generation and Characterization of a Human/Mouse Chimeric GD2-Mimicking Anti-Idiotype Antibody Ganglidiximab for Active Immunotherapy against Neuroblastoma.

Authors:  Christin Eger; Nikolai Siebert; Diana Seidel; Maxi Zumpe; Madlen Jüttner; Sven Brandt; Hans-Peter Müller; Holger N Lode
Journal:  PLoS One       Date:  2016-03-11       Impact factor: 3.240

7.  Racotumomab: an anti-idiotype vaccine related to N-glycolyl-containing gangliosides - preclinical and clinical data.

Authors:  Ana M Vázquez; Ana M Hernández; Amparo Macías; Enrique Montero; Daniel E Gómez; Daniel F Alonso; Mariano R Gabri; Roberto E Gómez
Journal:  Front Oncol       Date:  2012-10-23       Impact factor: 6.244

8.  Anti-ganglioside anti-idiotypic vaccination: more than molecular mimicry.

Authors:  Ana M H Vázquez; Nely Rodrèguez-Zhurbenko; Ana M V López
Journal:  Front Oncol       Date:  2012-11-20       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.